arrow
P

Paolo Manzoni

university of torino school of medicine
H指数:51
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

“Sustained clinical and epidemiological impact of Respiratory Syncitial Virus (RSV) in young infants exposed to universal immunization with Nirsevimab at birth: an italian multicenter, retrospective, cohort study 2024/25”

“新生儿出生时暴露于Nirsevimab普免接种后,呼吸道合胞病毒(RSV)在婴幼儿中的持续临床和流行病学影响:一项意大利多中心、回顾性、队列研究 2024/25”

2025-10-030
OAAI
Evaluation of a monoclonal antibody against respiratory syncytial virus, clesrovimab, in infants and children: Comprehensive rationale and study design for the late-stage clinical trials

评估抗呼吸道合胞病毒单克隆抗体clesrovimab在婴儿和儿童中的疗效:晚期临床试验的全面依据和研究设计

2025-09-014
PRE
Clesrovimab in Infants and Children at Increased Risk for Severe RSV Disease

Clesrovimab在患有严重RSV疾病风险增加的婴幼儿和儿童中的应用

2025-09-011
PRE
Systematic Review and Expert Consensus on the Use of Long-acting Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Disease: ARMADA (Advancing RSV Management And Disease Awareness) Taskforce

长效单克隆抗体在呼吸道合胞病毒疾病预防中的应用:系统评价与专家共识(ARMADA [推进RSV管理与疾病认知] 工作组)

2025-07-012
OAAI
Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children

二十五年来帕利珠单抗的应用:对其在全球范围内对儿童呼吸道合胞病毒疾病负担影响的回顾性研究

2025-04-010
OA